Novel Antibacterial Agents (Record no. 9882)

MARC details
000 -LEADER
fixed length control field 02766nam a2200133Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220615s9999||||xx |||||||||||||| ||und||
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783040000000
245 #0 - TITLE STATEMENT
Title Novel Antibacterial Agents
546 ## - LANGUAGE NOTE
Language note English[eng]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element saccharin||tetrazole||1,3,4-thiadiazole||H7PX glioma cells||antimicrobial screening||antioxidant capacity||oxidative stress||natural products||medicinal plants||anti-infective agents||alternative infection models||antibacterial||anticancer||GC-MS||LIBS||Moringa oleifera||seed extract||MRSA||marine bisindole alkaloids||antibiofilm activity||adjuvants agents||VBNC cells||indole||thioxothiazolidine||antibacterial activity||antifungal activity||computer-aided prediction||docking||Mur B||CYP 51||plant compounds||diarrhea||selectivity||compounds screening||quorum sensing inhibition||molecular docking||AMP||antimicrobial activity||antiviral activity||bacteriocin||COVID-19||disinfectant||Lactobacillus plantarum||plantaricin||carbon nanotubes||quaternary ammonium groups||hyperbranched dendritic polymers||antibacterial properties||anti-cyanobacterial properties||3D-printing||dental polymer||antibacterial agent||coating||mesoporous silica nanoparticles||polydimethylsiloxane||Leishmania tropica and infantum||antileishmanial agents||lucanthone analogues||amitriptyline analogues||quinolizidine-derived compounds||molecular modelling studies||covalent inhibitor||MurA||cyclobutenaminone||irreversible||methicillin-resistant Staphylococcus aureus||essential oils||Origanum majorana||Rosmarinus officinalis||Thymus zygis||biofilm inhibition and eradication||urushiol||3-pentylcatechol||3-pentadecylcatechol||Helicobacter pylori||antimicrobial||triple therapy||atopic dermatitis||skin barrier||cutaneous dysbiosis||Staphylococcus aureus||microbial therapy||drug delivery systems||tris(1H-indol-3-yl)methylium||turbomycin||indole derivatives||antibacterial action||overcoming of drug resistance||biological activities||essential oil||extract||Thymus mastichina||imidazole and imidazolium salts||amino acid||antibacterial agents||aggregation||lipophilicity||antimicrobial peptide||biomembranes||ESKAPE||antibiotic resistance||NMR||molecular dynamics||biophysics||sequence alignment||lytic infection||antibiotic-resistance||Mycobacterium tuberculosis||Acinetobacter baumannii||Pseudomonas aeruginosa||phage production||magistral phage||pulmonary delivery||oral administration||topical delivery||Pinus cembra L.||Pinus mugo Turra||Picea abies L.||Abies alba M.||chemical investigation||HS-GC/MS||antioxidant activity||tuberculosis||mycobactins||furan||siderophores||drug design||bioisosterism||drug resistance||n/a
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Meneghetti, Fiorella||Barlocco, Daniela
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/4830">https://mdpi.com/books/pdfview/book/4830</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E-Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre 15/06/2022   15/06/2022 15/06/2022 E-Books